DE69936234D1 - Verfahren und Zusammenstzung zur Hemmung des Wachtums von neoplastischen Zellen - Google Patents

Verfahren und Zusammenstzung zur Hemmung des Wachtums von neoplastischen Zellen

Info

Publication number
DE69936234D1
DE69936234D1 DE69936234T DE69936234T DE69936234D1 DE 69936234 D1 DE69936234 D1 DE 69936234D1 DE 69936234 T DE69936234 T DE 69936234T DE 69936234 T DE69936234 T DE 69936234T DE 69936234 D1 DE69936234 D1 DE 69936234D1
Authority
DE
Germany
Prior art keywords
growth
inhibiting
composition
neoplastic cells
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69936234T
Other languages
English (en)
Other versions
DE69936234T2 (de
Inventor
Avi Ashkenazi
Audrey Goddard
Austin L Gurney
Robert D Klein
Mary Napier
William I Wood
Jean Yuan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DE69936234D1 publication Critical patent/DE69936234D1/de
Application granted granted Critical
Publication of DE69936234T2 publication Critical patent/DE69936234T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69936234T 1998-10-13 1999-10-05 Verfahren und Zusammenstzung zur Hemmung des Wachtums von neoplastischen Zellen Expired - Lifetime DE69936234T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10408098P 1998-10-13 1998-10-13
US104080P 1998-10-13

Publications (2)

Publication Number Publication Date
DE69936234D1 true DE69936234D1 (de) 2007-07-12
DE69936234T2 DE69936234T2 (de) 2008-03-06

Family

ID=22298575

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69932342T Expired - Lifetime DE69932342T2 (de) 1998-10-13 1999-10-05 Verfahren und zusammensetzungen zur hemmung von neoplastischem zellwachstums
DE69936234T Expired - Lifetime DE69936234T2 (de) 1998-10-13 1999-10-05 Verfahren und Zusammenstzung zur Hemmung des Wachtums von neoplastischen Zellen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69932342T Expired - Lifetime DE69932342T2 (de) 1998-10-13 1999-10-05 Verfahren und zusammensetzungen zur hemmung von neoplastischem zellwachstums

Country Status (15)

Country Link
EP (1) EP1121439B1 (de)
JP (1) JP2002527452A (de)
KR (2) KR100448427B1 (de)
AT (2) ATE332970T1 (de)
AU (1) AU758462B2 (de)
CA (1) CA2344465A1 (de)
DE (2) DE69932342T2 (de)
DK (2) DK1121439T3 (de)
ES (2) ES2268901T3 (de)
IL (3) IL142088A0 (de)
MX (1) MXPA01003636A (de)
NZ (1) NZ510584A (de)
PT (2) PT1121439E (de)
WO (1) WO2000021996A2 (de)
ZA (1) ZA200102380B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7169906B2 (en) 1997-09-17 2007-01-30 Genentech, Inc. PRO211 polypeptides
US6974689B1 (en) 1997-09-18 2005-12-13 Genentech, Inc. Nucleic acid encoding PRO211 polypeptides
CA2406855A1 (en) * 2000-04-21 2001-11-01 Takeda Chemical Industries, Ltd. Novel insulin/igf/relaxin family polypeptides and dnas thereof
CA2710775A1 (en) * 2007-12-28 2009-07-09 Bioinvent International Ab Formulation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ226799A (en) * 1987-11-06 1991-08-27 Oncogen Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor
US5814307A (en) * 1989-04-10 1998-09-29 Bristol-Myers Squibb Company Method for regulating cell growth, leukocyte differentiation and tumor cell growth using Oncostatin M to stimulate synthesis of IL-6
US5416192A (en) * 1990-04-03 1995-05-16 Bristol-Myers Squibb Company Epithelins: novel cysteine-rich growth modulating proteins
AU9312198A (en) * 1997-09-17 1999-04-05 Genentech Inc. Genes amplified in tumours, antibodies against the proteins encoded thereby, andtheir use in diagnosis and treatment of cancer
NZ503343A (en) * 1997-09-17 2002-09-27 Genentech Inc Secreted and transmembrane polypeptides and use to induce apoptosis of tumour cells

Also Published As

Publication number Publication date
DE69932342D1 (de) 2006-08-24
DK1518930T3 (da) 2007-10-01
IL189502A0 (en) 2008-06-05
ES2268901T3 (es) 2007-03-16
IL142088A (en) 2008-11-26
EP1121439A2 (de) 2001-08-08
JP2002527452A (ja) 2002-08-27
PT1121439E (pt) 2006-12-29
WO2000021996A2 (en) 2000-04-20
KR100448427B1 (ko) 2004-09-16
AU1200500A (en) 2000-05-01
ZA200102380B (en) 2002-03-22
ATE332970T1 (de) 2006-08-15
ATE363536T1 (de) 2007-06-15
PT1518930E (pt) 2007-09-04
AU758462B2 (en) 2003-03-20
CA2344465A1 (en) 2000-04-20
MXPA01003636A (es) 2003-10-14
KR20010085915A (ko) 2001-09-07
DE69932342T2 (de) 2007-07-12
IL142088A0 (en) 2002-03-10
ES2290606T3 (es) 2008-02-16
WO2000021996A3 (en) 2000-11-09
KR100448426B1 (ko) 2004-09-13
KR20030096387A (ko) 2003-12-24
NZ510584A (en) 2003-04-29
EP1121439B1 (de) 2006-07-12
DK1121439T3 (da) 2006-11-13
DE69936234T2 (de) 2008-03-06

Similar Documents

Publication Publication Date Title
WO2003103581A3 (en) COMPOSITIONS AND METHODS FOR LIVER GROWTH AND PROTECTION
DE69918089D1 (de) Btk inhibitoren und verfahren zur identifizierung und verwendung
DE602004015811D1 (de) Verfahren zur inhibierung der proliferation von tumorzellen, bei dem platinkomplexe eingesetzt werden
MXPA05005398A (es) Meta para terapia de deterioro cognitivo.
DE69813898D1 (de) Substituierte porphyrinen
ATE294595T1 (de) Radioaktive zusammensetzungen zur behandlung von prostatatumoren
CY1109413T1 (el) Μεθοδοι θεραπειας πολλαπλου μυελωματος και διεγειρομενης απο μυελωμα επαναρροφησης οστου χρησιμοποιωντας ανταγωνιστες συνδεσης ιντεγκρινης/υποδοχεα
ATE193542T1 (de) Verfahren und verbindungen zum screening von presynaptischen calcium kanal inhibitoren
BRPI0411239A (pt) composto, processo para preparar o mesmo, composição farmacêutica, método para tratar ou prevenir um distúrbio que requer inibição de canal de potássio, e, uso de um composto
DE60021381D1 (de) Chinonverbindungen zur behandlung von krankheiten
DE69902523D1 (de) Verwendung von erythropoietin zur behandlung von multiple myelom
DE69905273D1 (de) Verfahren und zusammensetzung zur inhibierung der polymerisierung von ethylenisch ungesättigten kohlenwasserstoffen
ATE302002T1 (de) Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit
IL189502A0 (en) Methods and compositions for inhibiting neoplastic cell growth
DE60230133D1 (de) Toluolsulfonamid enthaltende antitumorale zusammensetzung und anwendungsverfahren dafür
DE60137721D1 (de) Inhibitoren von lyn-verbundener signaltransduktion (last) und deren verwendung zur behandlung von prostatakrebs
ATE338768T1 (de) Muc-1 derivate und deren verwendung zur behandlung von krebsassoziierter muc-1 mucin induzierter immunosuppression
WO2000012754A8 (en) Method for identifying substances for the treatment of c-jun-mediated disorders
WO2004096991A3 (en) Bcl2l12 polypeptide activators and inhibitors
EP1518930A3 (de) Verfahren und Zusammensetzung zur Hemmung des Wachsdums von neoplastischen Zellen
DE59904564D1 (de) Verwendung von acetylcholinesterase-inhibitoren zur behandlung von delirien
ATE280828T1 (de) Hemmung von alopezie
WO2000041472A3 (de) Bindungspartner für 5-ht5-rezeptoren zur migränebehandlung
WO2004009783A3 (en) Truncated rgr in t cell malignancy
ATE225660T1 (de) Verfahren zur verwendung von cyclooxygenase-2 hemmern zur behandlung und vorbeugung der demenz

Legal Events

Date Code Title Description
8364 No opposition during term of opposition